CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-17 | Teehan Brendan Chief Commercial Officer | Returned to the company | −100,934.27 | $36.50 | $3.7M | 0 |
| 2026-11-17 | Teehan Brendan Chief Commercial Officer | Returned to the company · Stock Option (Right to Buy) | −99,500 | 0 | ||
| 2026-02-11 | Teehan Brendan Chief Commercial Officer | Grant or award | +51,714 | 100,934.27 | ||
| 2026-01-30 | Teehan Brendan Chief Commercial Officer | Shares withheld for taxes | −5,182 | $20.54 | $106K | 49,220.27 |
| 2025-12-31 | Teehan Brendan Chief Commercial Officer | Grant or award | +402.27 | $10.76 | $4K | 54,402.27 |
| 2025-02-04 | Teehan Brendan Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +99,500 | $26.59 | $2.6M | 99,500 |
| 2025-02-01 | Teehan Brendan Chief Commercial Officer | Grant or award | +54,000 | 54,000 |
Page 1 of 1 · 7 trades